168 related articles for article (PubMed ID: 31966070)
1. TRIM59 as a novel molecular biomarker to predict the prognosis of patients with NSCLC.
Lou M; Gao Z; Zhu T; Mao X; Wang Y; Yuan K; Tong J
Oncol Lett; 2020 Feb; 19(2):1400-1408. PubMed ID: 31966070
[TBL] [Abstract][Full Text] [Related]
2. [Expression of TRIM59 in Non-small Cell Lung Cancer and Its Correlation with Prognosis].
Tian H; Zhang D; Xu R; Qin Y; Lan Y; Jiao W; Han Y
Zhongguo Fei Ai Za Zhi; 2020 Jan; 23(1):21-28. PubMed ID: 31948534
[TBL] [Abstract][Full Text] [Related]
3. TRIM59 is a novel potential prognostic biomarker in patients with non-small cell lung cancer: A research based on bioinformatics analysis.
Hao L; Du B; Xi X
Oncol Lett; 2017 Aug; 14(2):2153-2164. PubMed ID: 28789440
[TBL] [Abstract][Full Text] [Related]
4. Knockdown of tripartite motif 59 (TRIM59) inhibits proliferation in cholangiocarcinoma via the PI3K/AKT/mTOR signalling pathway.
Shen H; Zhang J; Zhang Y; Feng Q; Wang H; Li G; Jiang W; Li X
Gene; 2019 May; 698():50-60. PubMed ID: 30822475
[TBL] [Abstract][Full Text] [Related]
5. High expression of SLC6A10P contributes to poor prognosis in lung adenocarcinoma.
Yuan K; Gao ZJ; Yuan WD; Yuan JQ; Wang Y
Int J Clin Exp Pathol; 2018; 11(2):720-726. PubMed ID: 31938158
[TBL] [Abstract][Full Text] [Related]
6. TRIM59: A potential diagnostic and prognostic biomarker in human tumors.
Jin Z; Liu L; Yu Y; Li D; Zhu X; Yan D; Zhu Z
PLoS One; 2021; 16(9):e0257445. PubMed ID: 34534244
[TBL] [Abstract][Full Text] [Related]
7. Tripartite motif-containing 15 overexpression in non-small cell lung cancer is associated with poor patient prognoses.
Han X; Huang C; Qu X; Liu S; Yang X; Wang Y; Bie F; Liu Q; Du J
J Cancer; 2019; 10(4):843-852. PubMed ID: 30854090
[No Abstract] [Full Text] [Related]
8. TRIM59 knockdown blocks cisplatin resistance in A549/DDP cells through regulating PTEN/AKT/HK2.
He R; Liu H
Gene; 2020 Jul; 747():144553. PubMed ID: 32165307
[TBL] [Abstract][Full Text] [Related]
9. Potential value of tripartite motif-containing 59 as a biomarker for predicting the prognosis of patients with lung cancer: A protocol for systematic review and meta-analysis.
Guo J; Min K; Deng L
Medicine (Baltimore); 2021 Aug; 100(32):e26868. PubMed ID: 34397900
[TBL] [Abstract][Full Text] [Related]
10. TRIM59 regulates autophagy through modulating both the transcription and the ubiquitination of BECN1.
Han T; Guo M; Gan M; Yu B; Tian X; Wang JB
Autophagy; 2018; 14(12):2035-2048. PubMed ID: 30231667
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of TRIM59 for cancer patient survival: A systematic review and meta-analysis.
Wang M; Chao C; Luo G; Wang B; Zhan X; Di D; Qian Y; Zhang X
Medicine (Baltimore); 2019 Nov; 98(48):e18024. PubMed ID: 31770215
[TBL] [Abstract][Full Text] [Related]
12. TRIM59 Is a Novel Marker of Poor Prognosis and Promotes Malignant Progression of Ovarian Cancer by Inducing Annexin A2 Expression.
Wang Y; Zhou Z; Wang X; Zhang X; Chen Y; Bai J; Di W
Int J Biol Sci; 2018; 14(14):2073-2082. PubMed ID: 30585270
[TBL] [Abstract][Full Text] [Related]
13. Blockade of TRIM59 enhances esophageal cancer cell chemosensitivity to cisplatin by upregulating p53.
Liu R; Li H; Xu Y; Li X; Guo X; Shi J; Cui Y; Wang Z; Liu J
Oncol Lett; 2021 Jan; 21(1):6. PubMed ID: 33240412
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of tripartite motif 59 and its diagnostic utility in benign bowel diseases and colorectal cancer.
Dahpy MA; Salama RHM; Kamal AA; El-Deek HE; AbdelMotaleb AA; Abd-El-Rehim AS; Hassan EA; Alsanory AA; Saad MM; Ali M
J Biochem Mol Toxicol; 2022 Jul; 36(7):e23065. PubMed ID: 35377964
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic loss of putative tumor suppressor SFRP3 correlates with poor prognosis of lung adenocarcinoma patients.
Schlensog M; Magnus L; Heide T; Eschenbruch J; Steib F; Tator M; Kloten V; Rose M; Noetzel E; Gaisa NT; Knüchel R; Dahl E
Epigenetics; 2018; 13(3):214-227. PubMed ID: 27623992
[TBL] [Abstract][Full Text] [Related]
16. TRIM59 Promotes the Proliferation and Migration of Non-Small Cell Lung Cancer Cells by Upregulating Cell Cycle Related Proteins.
Zhan W; Han T; Zhang C; Xie C; Gan M; Deng K; Fu M; Wang JB
PLoS One; 2015; 10(11):e0142596. PubMed ID: 26599082
[TBL] [Abstract][Full Text] [Related]
17. Silencing Trim59 inhibits invasion/migration and epithelial-to-mesenchymal transition via TGF-β/Smad2/3 signaling pathway in bladder cancer cells.
Chen W; Zhao K; Miao C; Xu A; Zhang J; Zhu J; Su S; Wang Z
Onco Targets Ther; 2017; 10():1503-1512. PubMed ID: 28331343
[TBL] [Abstract][Full Text] [Related]
18. Tripartite Motif-Containing Protein 59 (TRIM59) Promotes Epithelial Ovarian Cancer Progression via the Focal Adhesion Kinase(FAK)/AKT/Matrix Metalloproteinase (MMP) Pathway.
Zhang P; Zhang H; Wang Y; Zhang P; Qi Y
Med Sci Monit; 2019 May; 25():3366-3373. PubMed ID: 31062766
[TBL] [Abstract][Full Text] [Related]
19. TRIM59 facilitates the proliferation of colorectal cancer and promotes metastasis via the PI3K/AKT pathway.
Sun Y; Ji B; Feng Y; Zhang Y; Ji D; Zhu C; Wang S; Zhang C; Zhang D; Sun Y
Oncol Rep; 2017 Jul; 38(1):43-52. PubMed ID: 28534983
[TBL] [Abstract][Full Text] [Related]
20. Skp2 expression has different clinicopathological and prognostic implications in lung adenocarcinoma and squamous cell carcinoma.
Zhong K; Yang F; Han Q; Chen J; Wang J
Oncol Lett; 2018 Sep; 16(3):2873-2880. PubMed ID: 30127874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
